Carlyle-backed Yipit has added M Science's CEO, Michael Marrale, to its complaint in its latest legal filing.

Jeffrey Eisele, the Chief Development Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.8 billion market cap biopharmaceutical company, recently sold a portion of his holdings in the ...

Hedge fund founder George Weiss filed a defamation suit in New York against Jefferies Financial (JEF), alleging the bank engaged in a “smear ...

"During the past 24 months or so, Apple has been the stock everyone has loved to hate, and that trend has continued into 2025," Rubin told clients in a new note. "Apple has been left behind in this ...

According to estimates by IDC and Canalys, overall iPhone market share fell 1% year over year in Q4 to 23% despite the ...

Apple Inc. was downgraded to perform from outperform at Oppenheimer, in the latest sign of caution building ahead of the ...

We recently published a list of the 12 Best Investment Websites To Research Stocks. In this article, we will look at where ...

The success of the startup raises questions about the heavy-investment AI model pursued by tech giants, despite their ...

The iPhone maker is expected to report revenues of $124.3 billion for the fiscal first quarter — an increase of more than 3% ...

The Nasdaq & S&P 500 fell after Chinese startup DeepSeek shows AI can be built cheaply, sparking fears AI spending will stall ...

Well-respected Apple analyst Ming-Chi Kuo has gone on record saying the Dynamic Island that sits atop the displays on the ...